12.85
+1.85(+16.82%)
Currency In USD
| Previous Close | 12.9 |
| Open | 12.92 |
| Day High | 13.29 |
| Day Low | 12.85 |
| 52-Week High | 63 |
| 52-Week Low | 10.83 |
| Volume | 95,131 |
| Average Volume | 83,819 |
| Market Cap | 180.33M |
| PE | -0.63 |
| EPS | -20.7 |
| Moving Average 50 Days | 14.75 |
| Moving Average 200 Days | 24.05 |
| Change | 0.08 |
If you invested $1000 in Catalyst Biosciences, Inc. (CBIO) 10 years ago, it would be worth $33,702.27 as of August 13, 2025 at a share price of $12.85. Whereas If you bought $1000 worth of Catalyst Biosciences, Inc. (CBIO) shares 5 years ago, it would be worth $55,505.16 as of August 13, 2025 at a share price of $12.85.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001 On Track to Submit IND Application for CR-001 in Fourth Quarter of 2025 with Proof-of-Concept Cli